science-product-detail
DOI: https://doi.org/10.1016/j.fertnstert.2020.05.022
Shortcomings of an unphysiological triggering of oocyte maturation using human chorionic gonadotropin
Claus Yding Andersen, D.M.Sc.a,b, Thomas Kelsey, Ph.D.c, Linn Salto Mamsen, Ph.D.a, and Lan Ngoc Vuong, M.D., Ph.D.d,e,f
Final maturation of follicles has, in connection with ovarian stimulation and infertility treatment, traditionally been achieved by the administration of a human chorionic gonadotropin (hCG) bolus trigger of 5,000 to 10,000 IU. This trigger serves two purposes: induce oocyte maturation; and serve as luteal phase support owing to its long half-life. It now appears that the hCG bolus trigger is unable to support both these two purposes optimally. In particular, after an hCG trigger, the early luteal phase is hormonally abnormal and different from conditions observed in the natural menstrual cycle: the timing of the initiation of hCG and progesterone rise is much faster after an hCG trigger than in a natural menstrual cycle; the maximal concentrations of hCG and progesterone considerably exceed those naturally observed; and the timing of the peak progesterone concentration after an hCG trigger is advanced several days compared with the natural cycle. Furthermore, the hCG trigger without any follicle-stimulating hormone activity may induce oocyte maturation less efficiently than the combined luteinizing hormone and follicle-stimulating hormone surge normally seen. Collectively, the endometrium is likely to be advanced after an hCG trigger, and the implantation potential is probably not optimal. The precise effect on pregnancy rates after the different progressions of hCG and progesterone concentrations during the early luteal phase has not yet been determined, but more individualized methods using more physiological approaches are likely to improve reproductive outcomes.
KEYWORDS:
Early luteal phase, early progesterone rise, endometrial advancement, hCG trigger
Download
Similar articles
-
Review The effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilization in women with a high antral follicle count
[ Vu N. A. Ho1,2,*, Sanne C. Braam3, Toan D. Pham1,2, Ben W. Mol4, and Lan N. Vuong2,5 ]
STUDY QUESTION: What is the effectiveness and safe...
- Review Standardizing definitions and reporting guidelines for the infertility core outcome set: an international consensus development study [ J M N Duffy 1 2, S Bhattacharya 3, S Bhattacharya 3, M Bofill 4, B Collura 5, C Curtis 6 7, J L H Evers 8, L C Giudice 9 10, R G Farquharson 11, S Franik 12, M Hickey 13, M L Hull 14, V Jordan 4, Y Khalaf 15, R S Legro 16, S Lensen 13, D Mavrelos 17, B W Mol 18, C Niederberger 19, E H Y Ng 20 21, L Puscasiu 22, S Repping 23 24, I Sarris 1, M Showell 25, A Strandell 26, A Vail 27, M van Wely 23, M Vercoe 25, N L Vuong 28, A Y Wang 29, R Wang 18, J Wilkinson 27, M A Youssef 30, C M Farquhar 4 25, Core Outcome Measure for Infertility Trials (COMMIT) initiative ]
Study question: Can consensus definitions for the core outcome set for inferti...
https://doi.org/10.1093/humrep/deaa243
- Review The Place of In Vitro Maturation in Assisted Reproductive Technology [ Lan N. Vuong1,2,*, Tuong M. Ho2, Robert B. Gilchrist3, Johan Smitz4 ]
In vitro maturation (IVM) is an assisted reproductive technology (ART) whereby immature cumul...
- Review Con: freeze-all for all? One size does not fit all [ Lan N. Vuong 1,2 ]
IVF has traditionally involved transfer of fresh embryos. However, a ‘freeze-all’ strategy where all embry...
- Review Effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilisation in women with high antral follicle count: study protocol for a randomised controlled trial [ Lan N Vuong1,2, Vu N A Ho2, Tuong M Ho2, Vinh Q Dang2, Tuan H Phung2, Nhu H Giang2, Anh H Le2, Toan D Pham2, Rui Wang3, Rob J Norman3,4, Johan Smitz5, Robert B Gilchrist6, Ben W Mol7 ]
Introduction In vitro maturation (IVM) is a potential alternative to conventional in vitro fertilisation (IVF) to avoi...
- Review Standardizing definitions and reporting guidelines for the infertility core outcome set: an international consensus development study [ J M N Duffy 1 2, S Bhattacharya 3, S Bhattacharya 3, M Bofill 4, B Collura 5, C Curtis 6 7, J L H Evers 8, L C Giudice 9 10, R G Farquharson 11, S Franik 12, M Hickey 13, M L Hull 14, V Jordan 4, Y Khalaf 15, R S Legro 16, S Lensen 13, D Mavrelos 17, B W Mol 18, C Niederberger 19, E H Y Ng 20 21, L Puscasiu 22, S Repping 23 24, I Sarris 1, M Showell 25, A Strandell 26, A Vail 27, M van Wely 23, M Vercoe 25, N L Vuong 28, A Y Wang 29, R Wang 18, J Wilkinson 27, M A Youssef 30, C M Farquhar 4 25, Core Outcome Measure for Infertility Trials (COMMIT) initiative ]